The Review Panel (MHRA)

The Review Panel (MHRA) carries out statutory and non-statutory reviews of proposals, decisions and provisional decisions taken by Medicines and Healthcare Products Regulatory Agency.

Role of the group

The terms of reference for the Review Panel (MHRA) are to:

  • review the provisional determinations made by the Medicines and Healthcare Products Regulatory Agency (MHRA) concerning the classification of a product as a medicine
  • perform the role of the ‘reviewers’ in relation to decisions or proposals made by the MHRA related to the grant, renewal, revocation, suspension, refusal or variation of manufacturer’s or wholesale dealing licences, and UK marketing authorisations (the ‘persons appointed’ role)
  • consider representations about decisions made in relation to advertising

The Review Panel became a departmental expert committee on 1 November 2012 as a result of the Arm’s Length Body (ALB) Review in 2010.

Current vacancies

If you are interested in joining the Review Panel, please apply via ECSRecruitment@mhra.gov.uk.

Annual report

The Review Panel Annual Report 2020

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use.

The Review Panel Annual Report 2019

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use.

The Review Panel Annual Report 2015

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use.

The Review Panel Annual Report 2014

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use.

The Review Panel Annual Report 2013

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use.

The Review Panel's guidance note for the hearing

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use.

Members

The members of the panel are:

  • Mr Neil Mercer LL.B. (Hons) B.A. (Hons) Practising Barrister, Thomas Bingham Chambers, London (Chair)
  • Mrs Elizabeth Bamford MRPhS Former Director of Regulatory, Medical & Consumer Affairs, GlaxoSmithKline Healthcare UK
  • Mr Richard Crossley LLB Non-executive Director, Fundraising Standards Board
  • Professor Nicola Robinson BSc (Hons) PhD DipHE LicAc Professor of Traditional Chinese Medicine (TCM) and Integrated Health, Faculty of Health and Social Care, London South Bank University

Reviewers (participation at specific appeals only) appointed under Sch 5 para 2 of the Human Medicines Regulations 2012 (as amended):

  • Dr Alan Fayaz MD(Res) MRCP FRCA FFPMRCA (University College London Hospital NHS Foundation Trust)
  • Dr Roger Knaggs BSc BMedSci PhD EDPM FFRPS FRPharmS FFPMRCA (University of Nottingham and Primary Integrated Community Solutions
  • Dr Matt Mulvey BSc (Hons) PhD (University of Leeds)
  • Dr Paul Farquhar-Smith MA, MB BChir, MA, PhD, FRCA, FFPMRCA (The Royal Marsden NHS Foundation Trust)